Leukemia, Myelodysplasia, Transplantation
News
FDA approves new formulation of drug for ALL
The US Food and Drug Administration (FDA) has approved the intravenous administration of asparaginase Erwinia chrysanthemi (Erwinaze). The...
Conference Coverage
CKT more important than del(17p) in CLL, group finds
The study showed that CKT, defined as 3 or more distinct chromosomal abnormalities, was independently associated with inferior event-free survival...
Conference Coverage
Study confirms IDH2 as therapeutic target in AML, MDS
in the Moscone Center SAN FRANCISCO—The first-in-human study of AG-221 has confirmed IDH2 as a therapeutic target in acute myeloid leukemia (AML...
News
Team identifies prognostic markers for CN-AML
Researchers say they’ve identified novel prognostic markers for older patients with cytogenetically normal acute myeloid leukemia (CN-AML). The...
Conference Coverage
Blinatumomab confirmed as treatment option in MRD+ ALL
SAN FRANCISCO—The first international, multicenter trial in acute lymphoblastic leukemia (ALL) using minimal residual disease (MRD) as a criterion...
Conference Coverage
Researchers show CTL019 cells proliferate and persist
Researchers at the University of Pennsylvania, working with CTL019 cells, are beginning to see both of these phenomena in children with relapsed,...
News
‘Father of hematopoietic cytokines’ dies
Photo courtesy of The Walter and Eliza Hall Institute of Medical Research Donald Metcalf, MD, an Australian researcher who has been called “the...
Conference Coverage
Iron chelation improves survival in lower-risk MDS
Photo courtesy of ASH SAN FRANCISCO—Iron chelation therapy significantly improves survival for patients with lower-risk myelodysplastic syndrome...
News
Reducing chemo drug’s cardiac side effects
Investigators have identified compounds that appear to prevent the cardiac damage caused by the chemotherapy drug doxorubicin. The compounds...
News
Weak magnetic fields not responsible for leukemia, study suggests
Research first carried out in the 1970s revealed an association between living near overhead power lines and an increased risk of childhood...
Conference Coverage
Two activin receptor fusion proteins show promise in anemia
site of the ASH Annual Meeting Photo courtesy of ASH SAN FRANCISCO—Two activin receptor fusion proteins, luspatercept and sotatercept, increased...